Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2016

Hexa Reports

Market Research Reports and Insightful Company Profiles

Chemotherapy Induced Peripheral Neuropathy

Market Size, Symptoms, Treatment, Causes, Analysis

and Pipeline Review, H1 2016

Global Markets Direct's, 'Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2016',

provides an overview of the Chemotherapy Induced Peripheral Neuropathy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for

Chemotherapy Induced Peripheral Neuropathy, complete with analysis by stage of development, drug

target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also

covers the descriptive pharmacological action of the therapeutics, its complete research and

development history and latest news and press releases. Additionally, the report provides an overview

of key players involved in therapeutic development for Chemotherapy Induced Peripheral Neuropathy

and features dormant and discontinued projects.

Browse Detail Report With TOC @ http://www.hexareports.com/report/chemotherapy-inducedperipheral-neuropathy-pipeline-review-h1-2016/details

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy

areas and nearly 3,000 indications. The report is built using data and information sourced from Global

Markets Direct's proprietary databases, company/university websites, clinical trial registries,

conferences, SEC filings, investor presentations and featured press releases from company/university

sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic

review following a stringent set of processes to ensure that all the profiles are updated with the latest

set of information. Additionally, various dynamic tracking processes ensure that the most recent

developments are captured on a real time basis.

Hexa Reports

Market Research Reports and Insightful Company...